Updates on Laboratory Evaluation of Feline Cardiac Diseases
Abstract
:1. Introduction
2. Laboratory Tests
2.1. Biochemical Profile
2.1.1. Cardiorenal Syndrome
2.1.2. Cardiohepatic Syndrome
2.1.3. Oxidative Stress
2.2. Hematological Profile
2.3. Coagulative Profile
2.4. Urinalysis
2.5. Effusion Analysis
2.6. Vector Borne Disease
2.7. Endocrinopathies
3. Cardiac Biomarkers
3.1. Cardiac Troponin
3.2. Natriuretic Peptides
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
References
- Gavazza, A.; Fruganti, A.; Turinelli, V.; Marchegiani, A.; Spaterna, A.; Tesei, B.; Rossi, G.; Cerquetella, M. Canine traditional laboratory tests and cardiac biomarkers. Front. Vet. Sci. 2020, 7, 1–9. [Google Scholar] [CrossRef]
- Hall, R.L.; Bender, H.S. Muscle. In Duncan & Prasse’s Veterinary Laboratory Medicine: Clinical Pathology; Wiley and Blackwell: Ames, IA, USA, 2011; pp. 283–294. [Google Scholar]
- Stockam, S.L.; Scott, M.A. Enzymes. In Fundamentals of Veterinary Clinical Pathology; Blackwell Publishing: Ames, IA, USA, 2008; pp. 640–669. [Google Scholar]
- Aroch, I.; Keidar, I.; Himelstein, A.; Schechter, M.; Shamir, M.H.; Segev, G. Diagnostic and prognostic value of serum creatinekinase activity in ill cats: A retrospective study of 601 cases. J. Feline Med. Surg. 2010, 12, 466–475. [Google Scholar] [CrossRef] [PubMed]
- Kidd, L.; Stepien, R.L.; Amrheiw, D.P. Clinical findings and coronary artery disease in dogs and cats with acute and subacute myocardial necrosis: 28 cases. J. Am. Anim. Hosp. Assoc. 2000, 36, 199–208. [Google Scholar] [CrossRef] [PubMed]
- Wray, J.D.; Gajanayake, I.; Smith, S.H. Congestive heart failure associated with a large transverse left ventricular moderator band in a cat. J. Feline Med. Surg. 2007, 9, 56–60. [Google Scholar] [CrossRef]
- Perez, C.; Hummel, J.B.; Keene, B.W.; Maggi, R.G.; Diniz, P.P.; Breitschwerdt, E.B. Successful treatment of Bartonella henselae endocarditis in a cat. J. Feline Med. Surg. 2010, 12, 483–486. [Google Scholar] [CrossRef]
- Palerme, J.S.; Jones, A.E.; Ward, J.L.; Balakrishnan, N.; Linder, K.E.; Breitschwerdt, E.B.; Keene, B.W. Infective endocarditis in 13 cats. J. Vet. Cardiol. 2016, 18, 213–225. [Google Scholar] [CrossRef]
- Hogan, D.F. Feline Cardiogenic Arterial Thromboembolism Prevention and Therapy. Vet. Clin. Small Anim 2017, 47, 1065–1082. [Google Scholar] [CrossRef] [PubMed]
- Smith, S.A.; Tobias, A.H.; Jacob, K.A.; Fine, D.M.; Grumbles, P.L. Arterial Thromboembolism in Cats: Acute Crisis in 127 Cases (1992–2001) and Long-Term Management with Low-Dose Aspirin in 24 Cases. J. Vet. Intern. Med. 2003, 17, 73–83. [Google Scholar] [PubMed]
- Boswood, A. Laboratory Test. In BSAVA Manual of Feline and Canine Cardiorespiratory Medicine; BSAVA: Gloucester, UK, 2010; pp. 60–66. [Google Scholar]
- Stockam, S.L.; Scott, M.A. Monovalent electrolytes and osmolality. In Fundamentals of Veterinary Clinical Pathology; Blackwell Publishing: Ames, IA, USA, 2008; pp. 497–545. [Google Scholar]
- van Hoek, I.; Hodgkiss-Geere, H.; Bode, E.F.; Hamilton-Elliott, J.; Mõtsküla, P.; Palermo, V.; Pereira, Y.M.; Culshaw, G.J.; Ivanova, A.; Dukes-McEwan, J. Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy. J. Vet. Int. Med. 2020, 34, 591–599. [Google Scholar] [CrossRef] [PubMed]
- Ronco, C.; Haapio, M.; House, A.A.; Anavekar, N.; Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 2008, 52, 1527–1539. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ronco, C.; Di Lullo, L. Cardiorenal syndrome. Heart Fail. Clin. 2014, 10, 251–280. [Google Scholar] [CrossRef]
- Pouchelon, J.L.; Atkins, C.E.; Bussadori, C.; Oyama, M.A.; Vaden, S.L.; Bonagura, J.D.; Chetboul, V.; Cowgill, L.D.; Elliot, J.; Francey, T.; et al. Cardiovascular-renal axis disorders in the domestic dog and cat: A veterinary consensus statement. J. Small Anim. Pract. 2015, 56, 537–552. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stockam, S.L.; Scott, M.A. Urinary System. In Fundamentals of Veterinary Clinical Pathology; Blackwell Publishing: Ames, IA, USA, 2008; pp. 416–487. [Google Scholar]
- Relford, R.; Robertson, J.; Clements, C. Symmetric Dimethylarginine Improving the Diagnosis and Staging of Chronic Kidney Disease in Small Animals. Vet. Clin. N. Am. Small Anim. Pract. 2016, 46, 941–960. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Braff, J.; Obare, E.; Yerramilli, M.; Elliott, J.; Yerramilli, M. Relationship between serum symmetric dimethylarginine concentration and glomerular filtration rate in cats. J. Vet. Intern. Med. 2014, 8, 1699–1701. [Google Scholar] [CrossRef]
- Hall, J.A.; Yerramilli, M.; Obare, E.; Yerramilli, M.; Jewell, D.E. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J. Vet. Intern. Med. 2014, 28, 1676–1683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Langhorn, R.; Kieler, I.N.; Koch, J.; Christiansen, L.B.; Jessen, L.R. Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus. J. Vet. Intern. Med. 2018, 32, 57–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, M.; Köster, L.S.; Fosgate, G.T.; Chadwick, C.C.; Sanz-González, Í.; Eckersall, P.D.; Wotton, P.R.; French, A.T. Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy. J. Vet. Intern. Med. 2020, 34, 1078–1090. [Google Scholar] [CrossRef]
- Poswiatowska-Kaszczyszyn, I. Usefulness of serum cystatin C measurement for assessing renal function in cats. Bull. Vet. Inst. Pulawy. 2012, 56, 235–239. [Google Scholar] [CrossRef] [Green Version]
- Ghys, L.; Meyer, E.; Paepe, D.; Delanghe, J.; Daminet, S. Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine. Vet. Clin. Pathol. 2014, 43, 226–234. [Google Scholar] [CrossRef]
- Xanthopoulos, A.; Starling, R.C.; Kitai, T.; Triposkiadis, F. Heart Failure and Liver Disease Cardiohepatic Interactions. J. Am. Coll. Cardiol. Heart Fail. 2019, 7, 87–97. [Google Scholar]
- Laribi, S.; Mebazaa, A. Cardiohepatic syndrome: Liver injury in decompensated heart failure. Curr. Heart Fail. Rep. 2014, 11, 236–240. [Google Scholar] [CrossRef] [PubMed]
- Rush, J.E.; Freeman, L.M.; Fenollosa, N.K.; Brown, D.J. Population and survival characteristics of cats with hypertrophic cardiomyopaty: 260 cases (1990–1999). J. Am. Vet. Med. Ass. 2002, 220, 202–207. [Google Scholar] [CrossRef]
- Hall, D.J.; Shofer, F.; Meier, C.K.; Sleeper, M.M. Pericardial effusion in cats: A retrospective study of clinical findings and outcome in 146 cats. J. Vet. Intern. Med. 2007, 21, 1002–1007. [Google Scholar] [CrossRef] [PubMed]
- König, A.; Hartmann, K.; Mueller, R.S.; Wess, G.; Schulz, B.S. Retrospective analysis of pleural effusion in cats. J. Feline Med. Surg. 2019, 21, 1102–1110. [Google Scholar] [CrossRef]
- Michałek, M.; Tabiś, A.; Pasławska, U.; Noszczyk-Nowak, A. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: A pilot study. BMC Vet. Res. 2020, 16, 26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Silverberg, D.S.; Wexler, D.; Blum, M.; Iaina, A. The cardio renal anemia syndrome: Correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin. Nephrol. 2003, 60, S93–S102. [Google Scholar] [PubMed]
- Volpe, M.; Tritto, C.; Testa, U.; Rao, M.A.; Martucci, R.; Mirante, A.; Enea, I.; Russo, R.; Rubattu, S.; Condorelli, G.L.; et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am. J. Cardiol. 1994, 74, 468–473. [Google Scholar] [CrossRef]
- Weiss, G.; Goodnough, L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352, 1011–1023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Androne, A.S.; Katz, S.D.; Lund, L.; LaManca, J.; Hudaihed, A.; Hryniewicz, K.; Mancini, D.M. Hemodilution is common in patients with advanced heart failure. Circulation 2003, 107, 226–229. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wilson, H.E.; Jasani, S.; Wagner, T.B. Signs of Left Heart Volume Overload in Severely Anemic Cats. J. Feline Med. Surg. 2010, 12, 904–909. [Google Scholar] [CrossRef]
- Kirby, D.; Gillick, A. Polycythemia and Tetralogy of Fallot in a Cat. Can. Vet. J. 1974, 15, 114–119. [Google Scholar]
- Levy, W.C.; Mozaffarian, D.; Linker, D.T.; Sutradhar, S.C.; Anker, S.D.; Cropp, A.B.; Anand, I.; Maggioni, A.; Burton, P.; Sullivan, M.D.; et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006, 113, 1424–1433. [Google Scholar] [CrossRef]
- Pocock, S.J.; Wang, D.; Pfeffer, M.A.; Yusuf, S.; McMurray, J.J.; Swedberg, K.B.; Ostergren, J.; Michelson, E.L.; Pieper, K.S.; Granger, C.B. Predictors of mortality and morbidity in patients with chronic heart failure. Eur. Heart J. 2006, 27, 65–75. [Google Scholar] [CrossRef] [Green Version]
- Stanzani, G.; Cowlam, R.; English, K.; Connolly, D.J. Evaluation of red blood cell distribution width in cats with hypertrophic cardiomyopathy. J. Vet. Card 2015, 17, S233–S243. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roderick, K.V.; Abelson, A.L.; Nielsen, L.; Price, L.L.; Quinn, R. Evaluation of red blood cell distribution width as a prognostic indicator in cats with acquired heart disease, with and without congestive heart failure. J. Feline Med. Surg. 2017, 19, 648–656. [Google Scholar] [CrossRef]
- Sykes, J.E.; Kittleson, M.D.; Chomel, B.B.; Macdonald, K.A.; Pesavento, P.A. Clinicopathologic findings and outcome In dogs with infective endocarditis: 71 cases (1992–2005). J. Am. Vet. Med. Ass. 2006, 228, 1735–1747. [Google Scholar] [CrossRef] [PubMed]
- Jordan, H.L.; Grindem, C.B.; Breitschwerdt, E.B. Thrombocytopenia in Cats: A Retrospective Study of 41 Cases. J. Vet. Intern. Med. 1993, 7, 262–265. [Google Scholar] [CrossRef] [PubMed]
- Ellis, J.; Bell, R.; Barnes, D.C.; Miller, R. Prevalence and disease associations in feline thrombocytopenia: A retrospective study of 194 cases. J. Small Anim. Pract. 2018, 59, 531–538. [Google Scholar] [CrossRef] [PubMed]
- Rizzo, F.; Tappin, S.W.; Tasker, S. Thrombocytosis in cats: A retrospective study of 51 cases (2000 e 2005). J. Feline Med. Surg. 2007, 9, 319–325. [Google Scholar] [CrossRef] [PubMed]
- Stockam, S.L.; Scott, M.A. Platelets. In Fundamentals of Vet. Clin Path, 2nd ed.; Stockam, S.L., Scott, M.A., Eds.; Blackwell Publishing: Ames, IA, USA, 2008; pp. 224–249. [Google Scholar]
- Welles, E.G.; Boudreaux, M.K.; Crager, C.S.; Tyler, J.W. Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease. Am. J. Vet. Res. 1994, 55, 619–627. [Google Scholar] [PubMed]
- Stokol, T.; Brooks, M.; Rush, J.E.; Rishniw, M.; Erb, H.; Rozanski, E.; Kraus, M.S.; Gelzer, A.R. Hypercoagulability in cats with cardiomyopathy. J. Vet. Intern. Med. 2008, 22, 546–552. [Google Scholar] [CrossRef]
- Helenski, C.A.; Ross, J.N. Platelet aggregation in feline cardiomyopathy. J. Vet. Intern. Med. 1987, 1, 24–28. [Google Scholar] [CrossRef] [PubMed]
- Baker, L.D.; Birk, P. Removal of aortic thrombi in the cat. Mod. Vet. Pract. 1974, 55, 303. [Google Scholar] [PubMed]
- Laste, N.J.; Harpster, N.K. A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977–1993. J. Am. Anim. Hosp. Assoc. 1995, 31, 450–492. [Google Scholar] [CrossRef]
- Jandrey, K.E.; Norris, J.W.; MacDonald, K.A.; Kittleson, M.D.; Tablin, F. Platelet function in clinically healthy cats and cats with hypertrophic cardiomyopathy: Analysis using the Platelet Function Analyzer-100. Vet. Clin. Path. 2008, 37, 385–388. [Google Scholar] [CrossRef]
- Bèdard, C.; Lanevschi-Pietersma, A.; Dunn, M. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy. Vet. Clin. Path. 2007, 36, 167–172. [Google Scholar] [CrossRef] [PubMed]
- Icli, A.; Aksoy, F.; Dogan, A.; Arslan, A.; Akcay, S.; Yücel, H.; Ersoy, I.; Gorgulu, O. Increased Mean Platelet Volume in Hypertrophic Cardiomyopathy. Angiology 2014, 65, 420–424. [Google Scholar] [CrossRef]
- Weikert, U.; Kuhl, U.; Schultheiss, H.P.; Rauch, U. Platelet Activation Is Increased in Patients With Cardiomyopathy: Myocardial Inflammation and Platelet Reactivity. Platelets 2002, 13, 487–491. [Google Scholar] [CrossRef] [PubMed]
- Yarom, R.; Lewis, B.S.; Lijovetzky, G.; Havivi, Y.; Chandler, J.A. Platelet studies in patients with hypertrophic cardiomyopathy. Cardiovasc. Res. 1982, 16, 324–330. [Google Scholar] [CrossRef]
- Soeki, T.; Tamura, Y.; Shinohara, H.; Sakabe, K.; Onose, Y.; Fukuda, N. Increased Soluble Platelet/Endothelial Cell Adhesion molecule-1 in the Early Stages of Acute Coronary Syndromes. Int. J. Cardiol. 2003, 90, 261–268. [Google Scholar] [CrossRef]
- Tablin, F.; Schumacher, T.; Pombo, M.; Marion, C.T.; Huang, K.; Norris, J.W.; Jandrey, K.E.; Kittleson, M.D. Platelet Activation in Cats with Hypertrophic Cardiomyopathy. J. Vet. Intern. Med. 2014, 28, 411–418. [Google Scholar] [CrossRef] [Green Version]
- Tripathi, N.K.; Gregory, C.R.; Latimer, K.S. Urinary system. In Duncan & Prasse’s Veterinary Laboratory Medicine: Clinical Pathology; Wiley e Blackwell: Ames, IA, USA, 2011; pp. 253–282. [Google Scholar]
- Barsanti, J.A. Urinary Disorders. In Small Animal: Clinical Diagnosis by Laboratory Methods; Elsevier: St Louis, MO, USA, 2012; pp. 125–155. [Google Scholar]
- Dempsey, S.M.; Ewing, P.J.E. A review of the pathophysiology, classification, and analysis of canine and feline cavitary effusion. J. Am. Anim. Hosp. Assoc. 2011, 47, 1–11. [Google Scholar] [CrossRef]
- Gavazza, A.; Turinelli, V.; Lubas, G. Effusion in the cat: Classification of 396 fluids according to a problem-oriented scheme. Comp. Clin. Pathol. 2013, 22, 517–521. [Google Scholar] [CrossRef]
- Amati, M.; Venco, L.; Roccabianca, P.; Santagostino, S.F.; Bertazzolo, W. Pericardial lymphoma in seven cats. J. Feline Med. Surg. 2014, 16, 507–512. [Google Scholar] [CrossRef] [PubMed]
- Davidson, B.J.; Paling, A.C.; Lahmers, S.L.; Nelson, O.L. Disease association and clinical assessment of feline pericardial effusion. J. Am. Anim. Hosp. Assoc. 2008, 44, 5–9. [Google Scholar] [CrossRef]
- Ruiz, M.D.; Vessières, F.; Ragetly, G.R.; Hernandez, J.L. Characterization of and factors associated with causes of pleural effusion in cats. J. Am. Vet. Med. Assoc. 2018, 253, 181–187. [Google Scholar] [CrossRef]
- Fossum, T.W.; Miller, M.W.; Rogers, K.S.; Bonagura, J.D.; Meurs, K.M. Chylothorax associated with right-sided heart failure in five cats. J. Am. Vet. Med. Assoc. 1994, 204, 84–89. [Google Scholar] [PubMed]
- Singh, A.; Brisson, B.A. Chylothorax associated with thrombosis of the cranial vena cava. Can. Vet. J. 2010, 51, 847–852. [Google Scholar]
- Pennisi, M.G.; Marsilio, F.; Hartmann, K.; Lloret, A.; Addie, D.; Belák, S.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Gruffydd-Jones, T.; et al. Bartonella species infection in cats: ABCD guidelines on prevention and management. J. Feline Med. Surg. 2013, 15, 563–569. [Google Scholar] [CrossRef] [PubMed]
- Chomel, B.B.; Wey, A.C.; Kasten, R.W.; Stacy, B.A.; Labelle, P. Fatal case of endocarditis associated with Bartonella henselae type I infection in a domestic cat. J. Clin. Microbiol. 2003, 41, 5337–5339. [Google Scholar] [CrossRef] [Green Version]
- Chomel, B.B.; Kasten, R.W.; Williams, C.; Wey, A.C.; Henn, J.B.; Maggi, R.; Carrasco, S.; Mazet, J.; Boulouis, H.J.; Maillard, R.; et al. Bartonella endocarditis: A pathology shared by animal reservoirs and patients. Ann. N. Y. Acad. Sci. 2009, 1166, 120–126. [Google Scholar] [CrossRef]
- Berdoulay, P.; Levy, J.K.; Snyder, P.S.; Pegelow, M.J.; Hooks, J.L.; Tavares, L.M.; Gibson, N.M.; Salute, M.E. Comparison of serological tests for the detection of natural heartworm infection in cats. J. Am. Anim. Hosp. Assoc. 2004, 40, 376–384. [Google Scholar] [CrossRef]
- American Heartworm Society. Official Guidelines from the American Heartworm Society. Available online: https://www.heartwormsociety.org/veterinary-resources/american-heartworm-society-guidelines (accessed on 7 January 2021).
- Pennisi, M.G.; Tasker, S.; Hartmann, K.; Belák, S.; Addie, D.; Boucraut-Baralon, C.; Egberink, H.; Frymus, T.; Hofmann-Lehmann, R.; Hosie, M.; et al. Dirofilarioses in cats European guidelines from the ABCD on prevention and management. J. Feline Med. Surg. 2020, 22, 442–451. [Google Scholar] [CrossRef] [PubMed]
- Kegler, K.; Nufer, U.; Alic, A.; Posthaus, H.; Olias, P.; Basso, W. Fatal infection with emerging apicomplexan parasite Hepatozoon silvestris in a domestic cat. Parasit. Vectors 2018, 11, 1–5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Peterson, M.E.; Ward, C.R. Etiopathologic findings of hyperthyroidism in cats. Vet. Clin. N. Am. Small Anim. Pract. 2007, 37, 633–645. [Google Scholar] [CrossRef] [PubMed]
- Carney, H.C.; Ward, C.R.; Bailey, S.J.; Bruyette, D.; Dennis, S.; Ferguson, D.; Hinc, A.; Rucinsky, A.R. AAFP Guidelines for the Management of Feline Hyperthyroidism. J. Feline Med. Surg. 2016, 18, 400–416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Broussard, J.D.; Peterson, M.E.; Fox, P.R. Changes in clinical and laboratory findings in cats with hyperthyroidism from 1983 to 1993. J. Am. Vet. Med. Assoc. 1995, 206, 302–305. [Google Scholar]
- Syme, H.M. Cardiovascular and renal manifestations of hyperthyroidism. Vet. Clin. N. Am. Small Anim. Pract. 2007, 37, 723–743. [Google Scholar] [CrossRef] [PubMed]
- Watson, N.; Murray, J.K.; Fonfara, S.; Hibbert, A. Clinicopathological features and comorbidities of cats with mild, moderate or severe hyperthyroidism: A radioiodine referral population. J. Feline Med. Surg. 2018, 20, 1130–1137. [Google Scholar] [CrossRef] [PubMed]
- Moise, N.S.; Dietze, A.E. Echocardiographic, electrocardiographic, and radiographic detection of cardiomegaly in hyperthyroid cats. Am. J. Vet. Res. 1986, 47, 1487–1494. [Google Scholar]
- Bond, B.R.; Fox, P.R.; Peterson, M.E.; Skavaril, R.V. Echocardiographic findings in 103 cats with hyperthyroidism. J. Am. Vet. Med. Assoc. 1988, 192, 1546–1549. [Google Scholar]
- Thoday, K.L.; Mooney, C.T. Historical, clinical and laboratory features of 126 hyperthyroid cats. Vet. Rec. 1992, 131, 257–264. [Google Scholar] [CrossRef]
- Daniel, G.B.; Neelis, D.A. Thyroid Scintigraphy in Veterinary Medicine. Semin. Nucl. Med. 2014, 44, 24–34. [Google Scholar] [CrossRef]
- Freeman, L.M. Beneficial effects of omega-3 fatty acids in cardiovascular disease. J. Small Anim. Pract. 2010, 51, 462–470. [Google Scholar] [CrossRef] [PubMed]
- Meurs, K.M.; Fox, P.R.; Miller, M.W.; Kapadia, S.; Mann, D.L. Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure. Am. J. Vet. Res. 2002, 63, 640–642. [Google Scholar] [CrossRef]
- Myers, J.A.; Lunn, K.F.; Bright, J.M. Echocardiographic findings in 11 cats with acromegaly. J. Vet. Intern. Med. 2014, 28, 1235–1238. [Google Scholar] [CrossRef] [Green Version]
- Kittleson, M.D.; Pion, P.D.; DeLellis, L.A.; Mekhamer, Y.; Dybdal, N.; Lothrop, C.D., Jr. Increased serum growth hormone concentration in feline hypertrophic cardiomyopathy. J. Vet. Intern. Med. 1992, 6, 320–324. [Google Scholar] [CrossRef]
- Oyama, M.A. Using Cardiac Biomarkers in Veterinary Practice. Clin. Lab. Med. 2015, 35, 555–566. [Google Scholar] [CrossRef]
- Baisan, R.A.; De Rosa, A.; Di Loria, A.; Vulpe, V.; Piantedosi, G. Cardiac biomarkers in clinical practice of dog and cat—A review. Hum. Vet. Med. 2016, 8, 50–58. [Google Scholar]
- Langhorn, R.; Willesen, J.L. Cardiac troponins in dogs and cats. J. Vet. Intern. Med. 2016, 30, 36–50. [Google Scholar] [CrossRef]
- Borgeat, K.; Conolly, D.J.; Luis Fuentes, V. Cardiac biomarkers in cats. J. Vet. Cardiol. 2015, 17, S74–S86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Herndon, W.E.; Kittleson, M.D.; Sanderson, K.; Drobatz, K.J.; Clifford, C.A.; Gelzer, A.; Summerfield, N.J.; Linde, A.; Sleeper, M.M. Cardiac troponin I in feline hypertrophic cardiomyopathy. J. Vet. Intern. Med. 2002, 16, 558–564. [Google Scholar] [CrossRef]
- Connolly, D.J.; Cannata, J.; Boswood, A.; Archer, J.; Groves, E.A.; Neiger, R. Cardiac troponin I in Cats with hypertrophic cardiomyopathy. J. Feline Med. Surg. 2003, 5, 209–216. [Google Scholar] [CrossRef]
- Langhorn, R.; Willesen, J.L.; Tarnow, I.; Kjelgaard-Hansen, M. Evaluation of a high-sensitivity assay for measurement of canine and feline serum cardiac troponin I. Vet. Clin. Pathol. 2013, 42, 490–498. [Google Scholar] [CrossRef] [PubMed]
- Hori, Y.; Iguchi, M.; Heishima, Y.; Yamashita, Y.; Nakamura, K.; Hirakawa, A.; Kitade, A.; Ibaragi, T.; Katagi, M.; Sawada, T.; et al. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy. J. Vet. Intern. Med. 2018, 32, 922–929. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hertzsch, S.; Roos, A.; Wess, G. Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats. J. Vet. Intern. Med. 2019, 33, 1242–1250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Porciello, F.; Rishniw, M.; Herndon, W.E.; Birettoni, F.; Antognoni, M.T.; Simpson, K.W. Cardiac troponin I is elevated in dogs and cats with azotaemia renal failure and in dogs with non-cardiac systemic disease. Aust. Vet. J. 2008, 86, 390–394. [Google Scholar] [CrossRef]
- Connolly, D.J.; Guitian, J.; Boswood, A.; Neiger, R. Serum troponin I levels in hyperthyroid cats before and after treatment with radioactive iodine. J. Feline Med. Surg. 2005, 7, 289–300. [Google Scholar] [CrossRef] [PubMed]
- Sangster, J.K.; Panciera, D.L.; Abbott, J.A.; Zimmerman, K.C.; Lantis, A.C. Cardiac biomarkers in hyperthyroid cats. J. Vet. Intern. Med. 2014, 28, 465–472. [Google Scholar] [CrossRef] [Green Version]
- Lalor, S.M.; Gunn-Moore, D.A.; Cash, R.; Foot, A.; Reed, N.; Mellanby, R.J. Serum cardiac troponin I concentrations in cats with anaemia—A preliminary, single-centre observational study. J. Small Anim. Pract. 2014, 55, 320–322. [Google Scholar] [CrossRef] [PubMed]
- Bijsmans, E.S.; Jepson, R.E.; Wheeler, C.; Syme, H.M.; Elliott, J. Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats. J. Vet. Intern. Med. 2017, 31, 650–660. [Google Scholar] [CrossRef] [Green Version]
- Novo Matos, J.; Pereira, N.; Glaus, T.; Wilkie, L.; Borgeat, K.; Loureiro, J.; Silva, J.; Law, V.; Kranjc, A.; Connolly, D.J.; et al. Transient Myocardial Thickening in Cats Associated with Heart Failure. J. Vet. Intern. Med. 2018, 32, 48–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Joseph, J.L.; Oxford, E.M.; Santilli, R.A. Transient myocardial thickening in a Bartonella henselaeepositive cat. J. Vet. Cardiol. 2018, 20, 198–203. [Google Scholar] [CrossRef]
- Langhorn, R.; Tarnow, I.; Willesen, J.L.; Kjelgaard-Hansen, M.; Skovgaard, I.M.; Koch, J. Cardiac troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy. J. Vet. Intern. Med. 2014, 28, 1485–1491. [Google Scholar] [CrossRef] [Green Version]
- Borgeat, K.; Sherwood, K.; Payne, J.R.; Luis Fuentes, V.; Connolly, D.J. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy. J. Vet. Intern. Med. 2014, 28, 1731–1737. [Google Scholar] [CrossRef]
- Herndon, W.E.; Rishniw, M.; Schrope, D.; Sammarco, C.D.; Boddy, K.N.; Sleeper, M.M. Assessment of plasma cardiac troponin I concentration as a means to differentiate cardiac and noncardiac causes of dyspnea in cats. J. Am. Vet. Med. Assoc. 2008, 233, 1261–1264. [Google Scholar] [CrossRef]
- Connolly, D.J.; Brodbelt, D.C.; Copeland, H.; Collins, S.; Fuentes, V.L. Assessment of the diagnostic accuracy of circulating cardiac troponin I concentration to distinguish between cats with cardiac and non-cardiac causes of respiratory distress. J. Vet. Cardiol. 2009, 11, 71–78. [Google Scholar] [CrossRef]
- Wells, S.M.; Shofer, F.S.; Walters, P.C.; Stamoulis, M.E.; Cole, S.G.; Sleeper, M.M. Evaluation of blood cardiac troponin I concentrations obtained with a cage-side analyzer to differentiate cats with cardiac and noncardiac causes of dyspnea. J. Am. Vet. Med. Assoc. 2014, 244, 425–430. [Google Scholar] [CrossRef]
- de Lima, G.V.; Ferreira, F.S. N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review. Vet. World 2017, 10, 1072–1082. [Google Scholar] [CrossRef]
- Hsu, A.; Kittleson, M.D.; Paling, A. Investigation into the use of plasma NTproBNP concentration to screen for feline hypertrophic cardiomyopathy. J. Vet. Cardiol. 2009, 1, S63–S70. [Google Scholar] [CrossRef]
- Singh, M.K.; Cocchiaro, M.F.; Kittleson, M.D. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats. J. Feline Med. Surg. 2010, 12, 942–947. [Google Scholar] [CrossRef]
- Wess, G.; Daisenberger, P.; Mahling, M.; Hirschberger, J.; Hartmann, K. Utility of measuring plasma N-terminal pro brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Vet. Clin. Pathol. 2011, 40, 237–244. [Google Scholar] [CrossRef]
- Fox, P.R.; Rush, J.E.; Reynolds, C.A.; Defrancesco, T.C.; Keene, B.W.; Atkins, C.E.; Gordon, S.G.; Schober, K.E.; Bonagura, J.D.; Stepien, R.L.; et al. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. J. Vet. Intern. Med. 2011, 25, 1010–1016. [Google Scholar] [CrossRef]
- MacLean, H.N.; Abbott, J.A.; Ward, D.L.; Huckle, W.R.; Sisson, D.D.; Pyle, R.L. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J. Vet. Intern. Med. 2006, 20, 284–289. [Google Scholar] [CrossRef]
- Ho Hori, Y.; Yamano, S.; Iwanaga, K.; Kano, T.; Tanabe, M.; Uechi, M.; Kanai, K.; Nakao, R.; Hoshi, F.; Higuchi, S. Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. J. Vet. Intern. Med. 2008, 22, 135–139. [Google Scholar] [CrossRef]
- Connolly, D.J.; Magalhaes, R.J.; Syme, H.M.; Boswood, A.; Fuentes, V.L.; Chu, L.; Metcalf, M. Circulating natriuretic peptides in cats with heart disease. J. Vet. Intern. Med. 2008, 22, 96–105. [Google Scholar] [CrossRef]
- Zimmering, T.M.; Meneses, F.; Nolte, I.J.; Simon, D. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy. Am. J. Vet. Res. 2009, 70, 216–222. [Google Scholar] [CrossRef]
- Machen, M.C.; Oyama, M.A.; Gordon, S.G.; Rush, J.E.; Achen, S.E.; Stepien, R.L.; Fox, P.R.; Saunders, A.B.; Cunningham, S.M.; Lee, P.M.; et al. Multi-centered investigation of a point-of care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation. J. Vet. Cardiol. 2014, 16, 245–255. [Google Scholar] [CrossRef]
- Mainville, C.A.; Clark, G.H.; Esty, K.J.; Foster, W.M.; Hanscom, J.L.; Hebert, K.J.; Lyons, H.R. Analytical validation of an immunoassay for the quantification of N-terminal pro–B-type natriuretic peptide in feline blood. J. Vet. Diagn. Investig. 2015, 27, 414–421. [Google Scholar] [CrossRef]
- Parzeniecka-Jaworska, M.; Garncarz, M.; Kluciński, W. ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats. Pol. J. Vet. Sci. 2016, 19, 801–807. [Google Scholar] [CrossRef] [Green Version]
- Harris, A.N.; Beatty, S.S.; Estrada, A.H.; Winter, B.; Bohannon, M.; Sosa, I.; Hanscom, J.; Mainville, C.A.; Gallagher, A.E. Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease. J. Vet. Intern. Med. 2017, 31, 994–999. [Google Scholar] [CrossRef] [PubMed]
- Heishima, Y.; Hori, Y.; Nakamura, K.; Yamashita, Y.; Isayama, N.; Kanno, N.; Katagi, M.; Onodera, H.; Yamano, S.; Aramaki, Y. Diagnostic accuracy of plasma atrial natriuretic peptide concentrations in cats with and without cardiomyopathies. J. Vet. Cardiol. 2018, 20, 234–243. [Google Scholar] [CrossRef] [PubMed]
- Smith, K.F.; Quinn, R.L.; Rahilly, L.J. Biomarkers for Differentiation of Causes of Respiratory Distress in Dogs and Cats: Part 1—Cardiac Diseases and Pulmonary Hypertension. J. Vet. Emerg. Crit. Care 2015, 25, 311–329. [Google Scholar] [CrossRef] [PubMed]
- Fox, P.R.; Oyama, M.A.; Reynolds, C.; Rush, J.E.; DeFrancesco, T.C.; Keene, B.W.; Atkins, C.E.; Macdonald, K.A.; Schober, K.E.; Bonagura, J.D.; et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J. Vet. Cardiol. 2009, 11, S51–S61. [Google Scholar] [CrossRef] [PubMed]
- Hassdenteufel, E.; Henrich, E.; Hildebrandt, N.; Stosic, A.; Schneider, M. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats. J. Vet. Emerg. Crit. Care 2013, 23, 416–422. [Google Scholar] [CrossRef]
- Humm, K.; Hezzell, M.; Sargent, J.; Connolly, D.J.; Boswood, A. Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations. J. Small Anim. Pract. 2013, 54, 656–661. [Google Scholar] [CrossRef]
- Hezzell, M.J.; Rush, J.E.; Humm, K.; Rozanski, E.A.; Sargent, J.; Connolly, D.J.; Boswood, A.; Oyama, M.A. Differentiation of cardiac from noncardiac pleural effusions in cats using second generation quantitative and point-of-care NT-proBNP Measurements. J. Vet. Intern. Med. 2016, 30, 536–542. [Google Scholar] [CrossRef] [Green Version]
- Wurtinger, G.; Henrich, E.; Hildebrandt, N.; Wiedemann, N.; Schneider, M.; Hassdenteufel, E. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats. BMC Vet. Res. 2017, 13, 1–7. [Google Scholar] [CrossRef]
- Singletary, G.E.; Rush, J.E.; Fox, P.R.; Stepien, R.L.; Oyama, M.A. Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs. J. Vet. Inter. Med. 2012, 26, 542–546. [Google Scholar] [CrossRef] [PubMed]
- Menaut, P.; Connolly, D.J.; Volk, A.; Pace, C.; Luis Fuentes, V.; Elliott, J.; Syme, H. Circulating natriuretic peptide concentrations in hyperthyroid cats. J. Small Anim. Pract. 2012, 53, 673–678. [Google Scholar] [CrossRef] [Green Version]
- Lalor, S.M.; Connolly, D.J.; Elliott, J.; Syme, H.M. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease. J. Vet. Cardiol. 2009, 11, S71–S79. [Google Scholar] [CrossRef]
- Syme, H.M.; Markwell, P.J.; Pfeiffer, D.; Elliott, J. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J. Vet. Intern. Med. 2006, 20, 528–535. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gavazza, A.; Marchegiani, A.; Guerriero, L.; Turinelli, V.; Spaterna, A.; Mangiaterra, S.; Galosi, L.; Rossi, G.; Cerquetella, M. Updates on Laboratory Evaluation of Feline Cardiac Diseases. Vet. Sci. 2021, 8, 41. https://doi.org/10.3390/vetsci8030041
Gavazza A, Marchegiani A, Guerriero L, Turinelli V, Spaterna A, Mangiaterra S, Galosi L, Rossi G, Cerquetella M. Updates on Laboratory Evaluation of Feline Cardiac Diseases. Veterinary Sciences. 2021; 8(3):41. https://doi.org/10.3390/vetsci8030041
Chicago/Turabian StyleGavazza, Alessandra, Andrea Marchegiani, Lorenza Guerriero, Vanessa Turinelli, Andrea Spaterna, Sara Mangiaterra, Livio Galosi, Giacomo Rossi, and Matteo Cerquetella. 2021. "Updates on Laboratory Evaluation of Feline Cardiac Diseases" Veterinary Sciences 8, no. 3: 41. https://doi.org/10.3390/vetsci8030041